glp 1 antidepressant Ozempic and antidepressants: What to know GLP-1's antidepressant effect may not

Semaglutide is a GLP-1 receptor agonist with approximately 94% sequence homology to native human GLP-1

Two controlled studies with semaglutide in schizophrenia are ongoing, 17,18 which we hope will inform expanded coverage of semaglutide in federal insurance programs

Patients should attend scheduled diabetes reviews where gastrointestinal symptoms, weight changes, and overall treatment response can be assessed

doi: 10.1093/aje/kwm106 3 BondsDELarsonJCSchwartzAVStrotmeyerESRobbinsJRodriguezBLet al

Bettadapura et al., 2024

With Tirzepatide (Zepbound) now having FDA approval for obesity, rumblings have again started about whether there will be increased price pressure and perhaps a reduction in cost for GLP-1s, which could bring increased access